Podcast: This Week in Managed CareFDA Committee Discuss EUA for J&J Vaccine and Other Health News
An FDA panel meets to discuss J&J's COVID-19 vaccine ahead of an expected emergency use authorization decision, cemiplimab approved for first-line advanced non\u2013small cell lung cancer with PD-L1 expression, and real-world outcomes contrast cancer clinical trial results in Medicare patients.